(Q38002290)

26 August 2017

Distinguishing comorbidity and successful management of adult ADHD. (English)

1 reference

adult attention deficit hyperactivity disorder

26 August 2017

1 reference

1 reference

Philip Asherson

3

0 references

Ron Akehurst

4

object named as

Ron Akehurst

1 reference

26 August 2017

J J Sandra Kooij

1

1 reference

26 August 2017

Michael Huss

2

1 reference

26 August 2017

Kathleen Beusterien

5

1 reference

26 August 2017

Alexis French

6

1 reference

26 August 2017

Rahul Sasané

7

1 reference

26 August 2017

Paul Hodgkins

8

1 reference

26 August 2017

12 April 2012

1 reference

Journal of Attention Disorders

26 August 2017

1 reference

26 August 2017

16

1 reference

26 August 2017

5 Suppl

1 reference

26 August 2017

3S-19S

1 reference

Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder

26 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Disentangling deficits in adults with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Gender differences in a sample of adults with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

The Efficacy of 2 Different Dosages of Methylphenidate in Treating Adults with Attention-Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Augmentation With Open-Label Atomoxetine for Partial or Nonresponse to Antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

The restless brain: attention-deficit hyperactivity disorder, resting-state functional connectivity, and intrasubject variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Periodic limb movement disorder of sleep in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Will population decreases in caffeine consumption unveil attention deficit disorders in adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Molecular genetics of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Substance use among ADHD adults: implications of late onset and subthreshold diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Attention-deficit/hyperactivity disorder in adults: recognition and diagnosis of this often-overlooked condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Comorbid Attention-Deficit/Hyperactivity Disorder in Borderline Patients Defines an Impulsive Subtype of Borderline Personality Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

The burden of untreated ADHD among adults: the role of stimulant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Behaviour, attention and cognition in severe dyslexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Seasonal affective symptoms in adults with residual attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Nonmedical use of prescription opioids and stimulants among student pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Methylphenidate effects on symptoms of attention deficit disorder in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Current issues around the pharmacotherapy of ADHD in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Childhood attention-deficit/hyperactivity disorder and the emergence of personality disorders in adolescence: a prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Attention deficit/hyperactivity disorder in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

The ADHD and sleep conundrum: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Sleep in adults with attention-deficit/hyperactivity disorder: a controlled polysomnographic study including spectral analysis of the sleep EEG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Intensified testing for attention-deficit hyperactivity disorder (ADHD) in girls should reduce depression and smoking in adult females and the prevalence of ADHD in the longterm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

The misuse and diversion of prescribed ADHD medications by college students

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Emotional dysregulation in adult ADHD and response to atomoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A combined treatment approach for adults with ADHD--results of an open study of 43 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Gender differences in ADHD: implications for psychosocial treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Gender differences in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Seasonality and circadian preference in adult attention-deficit/hyperactivity disorder: clinical and neuropsychological correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit-hyperactivity disorder in men with antisocial personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Role of the cerebellum in movements: control of timing or movement transitions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Nonstimulant treatment of adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

An experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Treatment of adult ADHD: is current knowledge useful to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Adult attention deficit hyperactivity disorder in an anxiety disorders population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Unveiling the mystery about adult ADHD: one woman's journey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Diagnostic issues for adolescents and adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Sleep and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

A qualitative study exploring the life-course experiences of young offenders with symptoms and signs of ADHD who were detained in a residential care setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

Cerebral glucose metabolism in adults with hyperactivity of childhood onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054711435361

21 January 2018

Identifiers

DOI

10.1177/1087054711435361

1 reference

26 August 2017

1 reference